Genor Biopharma Holdings (HKG:6998) said its chairman, Guo Feng, resigned due to other business commitments, according to a Friday filing with the Hong Kong bourse.
Separately, the company disclosed that it has appointed Weng Chengyi as its new chief financial officer.
Both changes took effect on Thursday.
Price (HKD): $1.65, Change: $+0.20, Percent Change: +13.79%